CSII - Cardiovascular Systems, Inc.
| Previous close | 29.55 |
| Open | 29.74 |
| Bid | 28.00 x 1000 |
| Ask | 0.00 x 900 |
| Day's range | 28.67 - 29.74 |
| 52-week range | 26.00 - 55.22 |
| Volume | 389,967 |
| Avg. volume | 336,985 |
| Market cap | 1.155B |
| Beta (5Y monthly) | 1.46 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.31 |
| Earnings date | 04 Aug 2020 - 10 Aug 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 45.86 |
- Motley Fool
Shockwave Medical Stock Falls After Two Patents Ruled Invalid
Shares of cardiovascular-health company Shockwave Medical (NASDAQ: SWAV) fell on Thursday after the Patent Trial and Appeal Board ruled that two of its patents are invalid. Previously, fellow healthcare-company Cardiovascular Systems (NASDAQ: CSII) challenged two of Shockwave Medical's patents and asked the U.S. Patent and Trademark Office to look into it. The '371 patent adds a couple of electrodes inside a balloon catheter to help break up calcification in blood vessels.
- Business Wire
Cardiovascular Systems Announces Exercise of Underwriters’ Option
Cardiovascular Systems Announces Exercise of Underwriters’ Option
- Business Wire
Cardiovascular Systems, Inc. to Present at the Raymond James Human Health Innovation Conference
CARDIOVASCULAR SYSTEMS, INC. TO PRESENT AT THE RAYMOND JAMES HUMAN HEALTH INNOVATION CONFERENCE
- Motley Fool
Why Cardiovascular Systems Is Down Today
Shares of Cardiovascular Systems (NASDAQ: CSII) are down by 10.2% as of 1:00 p.m. EDT on Wednesday after the company announced the pricing of a public offering of common stock on Tuesday evening. Shares of Cardiovascular Systems were worth a little under $38.50 apiece at the close of market on Tuesday. Also, Cardiovascular Systems is giving underwriters the option to purchase an additional 551,470 shares within 30 days.
- Business Wire
Cardiovascular Systems Prices Public Offering of Common Stock
Cardiovascular Systems Prices Public Offering of Common Stock
- Business Wire
Cardiovascular Systems Announces Proposed Public Offering of Common Stock
CARDIOVASCULAR SYSTEMS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
- Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2020 Third-Quarter Financial Results
CARDIOVASCULAR SYSTEMS, INC. REPORTS FISCAL 2020 THIRD-QUARTER FINANCIAL RESULTS
- Business Wire
Cardiovascular Systems, Inc. to Webcast Fiscal 2020 Third-Quarter Earnings Conference Call Tuesday, May 5
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2020 third-quarter conference call on Tuesday, May 5, 2020.
- GlobeNewswire
Beta Bionics Appoints Martha Aronson and Sean Carney to Its Board as Independent Directors
Beta Bionics, Inc. — a medical technology company developing and aiming to commercialize the world’s first fully automated bionic pancreas system called the iLet® today announced that Martha G. Aronson and Sean D. Carney have been appointed to the Company’s Board of Directors effective immediately.
- Simply Wall St.
Should You Be Concerned About Cardiovascular Systems, Inc.'s (NASDAQ:CSII) Historical Volatility?
If you own shares in Cardiovascular Systems, Inc. (NASDAQ:CSII) then it's worth thinking about how it contributes to...
- Zacks
Cardiovascular Systems (CSII) Loss Wider Than Estimates in Q2
We are upbeat about Cardiovascular Systems' (CSII) year-over-year uptick in global Coronary and peripheral device revenues during Q2.
- Zacks
Cardiovascular Systems (CSII) Reports Q2 Loss, Tops Revenue Estimates
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -233.33% and 0.65%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Analysts Estimate Cardiovascular Systems (CSII) to Report a Decline in Earnings: What to Look Out for
Cardiovascular Systems (CSII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Cardiovascular Systems (CSII) Stock Hits New 52-Week High
Cardiovascular Systems (CSII) is optimistic about maintaining its growth momentum on several recent developments.
- Simply Wall St.
Update: Cardiovascular Systems (NASDAQ:CSII) Stock Gained 79% In The Last Year
If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can significantly...
- Zacks
Cardiovascular Systems Sees Peripheral OAS Micro Crown Success
This is a major achievement for Cardiovascular Systems (CSII) toward strengthening its portfolio for the treatment of CLI.
- Zacks
Cardiovascular Systems (CSII) Up 6.2% Since Last Earnings Report: Can It Continue?
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Cardiovascular Systems (CSII) Loss Wider Than Estimates in Q1
We are upbeat about the year-over-year uptick in both Coronary and peripheral device revenues within Cardiovascular Systems' (CSII) domestic market.
- Zacks
Cardiovascular Systems (CSII) Reports Q1 Loss, Tops Revenue Estimates
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -88.89% and 0.72%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
How Many Cardiovascular Systems, Inc. (NASDAQ:CSII) Shares Did Insiders Buy, In The Last Year?
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
- Simply Wall St.
Does Cardiovascular Systems, Inc. (NASDAQ:CSII) Have A Particularly Volatile Share Price?
Anyone researching Cardiovascular Systems, Inc. (NASDAQ:CSII) might want to consider the historical volatility of the...
- Zacks
Cardiovascular Systems Set to Present LIBERTY 360 Outcome
This study outcome is expected to be a major stride forward in Cardiovascular Systems' (CSII) endeavor to offer treatment to patients of multi-level peripheral artery disease (PAD).
- Motley Fool
Cardiovascular Systems Inc (CSII) Q4 2019 Earnings Call Transcript
CSII earnings call for the period ending June 30, 2019.
- Zacks
Cardiovascular Systems (CSII) Earnings Match Estimates in Q4
We are upbeat about the year-over-year uptick in Coronary and peripheral device revenues within Cardiovascular Systems' (CSII) domestic market.
